Apellis Pharmaceuticals general counsel sells $20,518 in stock
David O. Watson, the General Counsel of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), recently sold a portion of his holdings ...
North Face Parent VF Corp's Q3 Marks First Revenue Growth In Nine Quarters, But Goldman Sachs Stays Neutral
Goldman Sachs analyst Brooke Roach reiterated a Neutral rating on the shares of VF Corp (NYSE:VFC) and raised the price ...
Apellis Pharmaceuticals chief development officer sells $8,207 in stock
Jeffrey Eisele, the Chief Development Officer at Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), a $3.8 billion market cap biopharmaceutical company, recently sold a portion of his holdings in the ...